Home › Liver Cancer (Hepatocellular Carcinoma) › District of Columbia
Liver Cancer (Hepatocellular Carcinoma) clinical trials in District of Columbia
4 studies for Liver Cancer (Hepatocellular Carcinoma) are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Evaluating Novel Therapies in ctDNA Positive GI Cancers
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05482516Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's National Medical Center, Washington D.C.
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Recruiting
Ages 18 to 75 · All sexes · Updated Jun 17, 2026 · NCT05486572From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.